Detailed information for compound 1602134

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 497.438 | Formula: C22H26Cl2N4O3S
  • H donors: 2 H acceptors: 3 LogP: 4.68 Rotable bonds: 7
    Rule of 5 violations (Lipinski): 1
  • SMILES: O=C(Nc1cccc(c1Cl)Cl)Nc1sc(cc1C(=O)N1CCC(=O)N(CC1)C)C(C)(C)C
  • InChi: 1S/C22H26Cl2N4O3S/c1-22(2,3)16-12-13(20(30)28-9-8-17(29)27(4)10-11-28)19(32-16)26-21(31)25-15-7-5-6-14(23)18(15)24/h5-7,12H,8-11H2,1-4H3,(H2,25,26,31)
  • InChiKey: AIMPIOYNXLAVIB-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens mitogen-activated protein kinase 14 Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Trypanosoma brucei gambiense mitogen-activated protein kinase 3, putative Get druggable targets OG5_128610 All targets in OG5_128610
Echinococcus multilocularis mitogen activated protein kinase 14 Get druggable targets OG5_128610 All targets in OG5_128610
Echinococcus granulosus mitogen activated protein kinase 14 Get druggable targets OG5_128610 All targets in OG5_128610
Trypanosoma cruzi mitogen-activated protein kinase 3, putative Get druggable targets OG5_128610 All targets in OG5_128610
Candida albicans MAP kinase involved in osmoregulation Get druggable targets OG5_128610 All targets in OG5_128610
Schistosoma japonicum ko:K04441 p38 MAP kinase, putative Get druggable targets OG5_128610 All targets in OG5_128610
Leishmania mexicana mitogen-activated protein kinase 3, putative,map kinase 3, putative Get druggable targets OG5_128610 All targets in OG5_128610
Trypanosoma congolense mitogen-activated protein kinase 3, putative Get druggable targets OG5_128610 All targets in OG5_128610
Echinococcus multilocularis mitogen activated protein kinase 11 Get druggable targets OG5_128610 All targets in OG5_128610
Brugia malayi P38 map kinase family protein 2 Get druggable targets OG5_128610 All targets in OG5_128610
Trypanosoma brucei mitogen-activated protein kinase 3, putative Get druggable targets OG5_128610 All targets in OG5_128610
Echinococcus multilocularis mitogen activated protein kinase 14 Get druggable targets OG5_128610 All targets in OG5_128610
Leishmania major mitogen-activated protein kinase 3, putative,map kinase 3, putative Get druggable targets OG5_128610 All targets in OG5_128610
Echinococcus multilocularis mitogen activated protein kinase 11 Get druggable targets OG5_128610 All targets in OG5_128610
Leishmania braziliensis mitogen-activated protein kinase 3, putative,map kinase 3, putative Get druggable targets OG5_128610 All targets in OG5_128610
Trypanosoma cruzi mitogen-activated protein kinase 3, putative Get druggable targets OG5_128610 All targets in OG5_128610
Loa Loa (eye worm) CMGC/MAPK/P38 protein kinase Get druggable targets OG5_128610 All targets in OG5_128610
Echinococcus granulosus mitogen activated protein kinase 11 Get druggable targets OG5_128610 All targets in OG5_128610
Candida albicans MAP kinase involved in osmoregulation Get druggable targets OG5_128610 All targets in OG5_128610
Leishmania donovani mitogen-activated protein kinase 3, putative Get druggable targets OG5_128610 All targets in OG5_128610
Leishmania infantum mitogen-activated protein kinase 3, putative,map kinase 3, putative Get druggable targets OG5_128610 All targets in OG5_128610

By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Trypanosoma brucei mitogen-activated protein kinase 5 mitogen-activated protein kinase 14 360 aa 336 aa 33.3 %

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Brugia malayi kinase, mitochondrial precursor 0.1114 0.604 1
Schistosoma mansoni pyruvate dehydrogenase 0.1114 0.604 0.0895
Echinococcus multilocularis Pyruvate dehydrogenase (lipoamide) kinase 0.1114 0.604 0.604
Echinococcus multilocularis p2X purinoceptor 4 0.1744 1 1
Echinococcus granulosus p2X purinoceptor 4 0.1744 1 1
Leishmania major pyruvate dehydrogenase (lipoamide) kinase, putative 0.0389 0.149 0.2467
Echinococcus granulosus Pyruvate dehydrogenase lipoamide kinase 0.1114 0.604 0.604
Schistosoma mansoni P2X receptor subunit 0.1744 1 1
Trypanosoma cruzi developmentally regulated phosphoprotein, putative 0.1114 0.604 1
Schistosoma mansoni P2X receptor subunit 0.1744 1 1
Toxoplasma gondii ATPase/histidine kinase/DNA gyrase B/HSP90 domain-containing protein 0.0451 0.188 1
Loa Loa (eye worm) hypothetical protein 0.1114 0.604 1
Schistosoma mansoni P2X receptor subunit 0.1744 1 1
Echinococcus multilocularis p2X purinoceptor 4 0.1744 1 1
Trypanosoma brucei developmentally regulated phosphoprotein 0.1114 0.604 1
Echinococcus granulosus p2X purinoceptor 4 0.1744 1 1
Trypanosoma cruzi pyruvate dehydrogenase (lipoamide) kinase, putative 0.0389 0.149 0.2467
Leishmania major developmentally regulated phosphoprotein-like protein 0.1114 0.604 1
Echinococcus multilocularis p2X purinoceptor 4 0.1744 1 1
Schistosoma mansoni P2X receptor subunit 0.1744 1 1
Trypanosoma brucei pyruvate dehydrogenase (lipoamide) kinase, putative 0.0389 0.149 0.2467
Echinococcus multilocularis Pyruvate dehydrogenase (lipoamide) kinase 0.1114 0.604 0.604

Activities

Activity type Activity value Assay description Source Reference
IC50 (binding) = 0.039 uM Inhibition of p38alpha assessed as [33P]gamma-ATP incorporation into GST-ATF2 substrate preincubated for 20 mins before substrate addition measured after 70 mins by liquid scintillation counter ChEMBL. 22014550
IC50 (functional) = 0.52 uM Antiinflammatory activity in human PBMC assessed as inhibition of LPS-induced TNFalpha production preincubated for 1 hr before LPS challenge measured after 3 hrs by ELISA ChEMBL. 22014550
IC50 (functional) = 6.7 uM Antiinflammatory activity in human PBMC assessed as inhibition of LPS-induced TNFalpha production preincubated for 1 hr before LPS challenge measured after 3 hrs by ELISA in presence of fresh human frozen plasma ChEMBL. 22014550

Phenotypes

Whole-cell/tissue/organism interactions

Species name Source Reference Is orphan
Homo sapiens ChEMBL23 22014550

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.